ROCHESTER, N.Y., APRIL 21, 2015. VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, announces that they have implemented the imaging data and query management digital platform, TrialTracker™ that was licensed from alliance partner, IXICO plc, in December 2014. Operational metrics from the initial clinical trials that have been deployed using TrialTracker™ have met or exceeded all expectations for performance.
“Imaging sites are at the heart of all clinical trials for VirtualScopics,” said Ron Way, Vice President of Operations at VirtualScopics. “Providing sites with the very best tools for safe, reliable and efficient transfer of this precious research information is why we chose to work with IXICO, and to deploy TrialTracker™ and Site Interface. We expect our deployment to accelerate very quickly, now that our proof points have been met.”
Data Queries are a necessary though burdensome part of almost every clinical trial. Sites using TrialTracker Site Interface can now manage their entire set of image data transfer activities, including transfer dates, compliance with privacy regulations governing personal health information (PHI) and resolution of data queries with a single intuitive application.
“When you make it easier for sites to work with you,” explained Mr. Way, “the outcomes include a faster turnaround time from acquisition to image transfer, a reduced number and faster resolution of data queries as well as substantial reductions in elapsed time before image analysis can begin. That’s a win for the sites, a win for VirtualScopics and most importantly, a big win for our sponsors.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.